# Lipopolysaccharide induced mouse depression model can better simulate changes in peripheral blood FFAs in alMDD

**Authors:** Jincai Pan, Guanxi Liu, Yuyuan Wang, Yuting Lan, Yanmei Liang, Weicheng Li, Kexin Zhu, Yanling Zhou, Yuping Ning

PMC · DOI: 10.1371/journal.pone.0340967 · PLOS One · 2026-01-23

## TL;DR

A mouse model of depression induced by lipopolysaccharide better reflects fatty acid changes seen in adolescent MDD patients compared to other models.

## Contribution

The LPS-induced model is shown to be a more reliable preclinical model for simulating fatty acid alterations in adolescent MDD.

## Key findings

- Peripheral blood FFAs levels are significantly reduced in adolescent MDD patients.
- The LPS-induced model better recapitulates FFAs profile changes in MDD compared to CSDS.
- Specific fatty acids like C16:1 and C14:0 in LPS mice align more closely with alMDD profiles.

## Abstract

Numerous studies have highlighted a strong association between free fatty acids (FFAs) and major depressive disorder (MDD), however, the underlying mechanisms remain poorly understood. Here, we demonstrate that peripheral blood FFAs levels are significantly reduced in adolescent patients with MDD (alMDD), as quantified by gas chromatography–mass spectrometry (GC-MS), providing critical insights for preclinical depression research. Both chronic social defeat stress (CSDS) and lipopolysaccharide (LPS) models induced depression-like behaviors and triggered varying degrees of variant expressions in peripheral blood FFAs in mice. Specifically, the LPS-induced model generally exhibited superior fidelity in recapitulating the items of FFAs profile of MDD patients. Notably, hexanoic acid (C6:0), nonanoic acid (C9:0) and nonadecylic acid (C19:0) levels in CSDS mice showed closer alignment with those in alMDD individuals, whereas, cis-9-palmitoleic acid (C16:1), and myristic acid (C14:0) levels in LPS mice more accurately simulated the FFAs alterations observed in alMDD. Collectively, this study identifies the LPS-induced depression-like model as a more reliable proxy for investigating FFAs dysregulation in alMDD.

## Linked entities

- **Chemicals:** hexanoic acid (PubChem CID 8892), nonanoic acid (PubChem CID 8158), nonadecylic acid (PubChem CID 12591), cis-9-palmitoleic acid (PubChem CID 445638), myristic acid (PubChem CID 11005)
- **Diseases:** major depressive disorder (MONDO:0002009), MDD (MONDO:0012048)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Diseases:** lipid (MESH:D011017), MDD (MESH:D003865), neurological, endocrine, autoimmune, or infectious diseases (MESH:D003141), asthma (MESH:D001249), PLS (MESH:D010214), seizure disorders (MESH:D004827), inflammatory bowel disease (MESH:D015212), alcohol/substance use disorders (MESH:D000437), traumatic brain injury (MESH:D000070642), bulimia (MESH:D002032), social dysfunction (MESH:D000067404), CSDS (MESH:D013313), Mental Disorders (MESH:D001523), dislocation (MESH:D004204), suicidal ideation (MESH:D001072), pain (MESH:D010146), coronary artery disease (MESH:D003324), somatoform disorders (MESH:D013001), suicidal tendencies (MESH:C536965), arthritis (MESH:D001168), anxiety (MESH:D001007), loss of consciousness (MESH:D014474), allergic inflammation (MESH:D007249), affective-like disorders (MESH:D019964), HC (MESH:D000067329), Chronic social defeat (MESH:D002908), psychotic (MESH:D011618), Depression (MESH:D003866), functional impairment (MESH:D003072), anxiety disorders (MESH:D001008)
- **Chemicals:** C14:0 (-), pentadecanoic acid (MESH:C117025), heptadecanoic acid (MESH:C013102), FFA (MESH:D005230), lipid (MESH:D008055), nonanoic acid (MESH:C008776), palmitoleic acid (MESH:C008757), omega-3 polyunsaturated fatty acids (MESH:D010743), saline (MESH:D012965), water (MESH:D014867), LPS (MESH:D008070), trans-9-octadecenoic acid (MESH:C011459), fluoxetine (MESH:D005473), alcohol (MESH:D000438), MC (MESH:C061001), nonadecanoic acid (MESH:C517969), hexanoic acid (MESH:C037652), Sucrose (MESH:D013395), myristic acid (MESH:D019814)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** /6J — Homo sapiens (Human), Cutaneous melanoma, Cancer cell line (CVCL_W797), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12829858/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12829858/full.md

## References

50 references — full list in the complete paper: https://tomesphere.com/paper/PMC12829858/full.md

---
Source: https://tomesphere.com/paper/PMC12829858